source
- First wave of ASH 2026 abstracts released, featuring data from J&J, Servier and AstraZenecaThe American Society of Hematology’s annual meeting is set for New Orleans, Louisiana, a little over a month away. The first batch of abstracts for the conference has been posted, showcasing early…
- Novo claims 80% share of oral GLP-1 market as rivalry with Lilly intensifiesNovo's CEO Mike Maziar Doustdar said the company leads the oral GLP-1 market, stating the Wegovy pill holds about 80% of prescriptions since its launch in January. Eli Lilly, however, reported tha…